COFCO Biotechnology Co., Ltd.

000930.SZ · SHZ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & EquivalentsCN¥1,909CN¥1,481CN¥1,017CN¥1,116
Short-Term InvestmentsCN¥0CN¥0CN¥0CN¥0
ReceivablesCN¥1,363CN¥1,124CN¥1,487CN¥1,452
InventoryCN¥2,770CN¥2,534CN¥3,763CN¥4,052
Other Curr. AssetsCN¥483CN¥894CN¥283CN¥1,276
Total Curr. AssetsCN¥6,810CN¥6,035CN¥7,671CN¥7,634
Property Plant & Equip (Net)CN¥8,612CN¥8,678CN¥8,612CN¥8,650
GoodwillCN¥366CN¥366CN¥366CN¥366
IntangiblesCN¥602CN¥603CN¥611CN¥630
Long-Term InvestmentsCN¥548CN¥535CN¥537CN¥537
Tax AssetsCN¥280CN¥265CN¥165CN¥203
Other NC AssetsCN¥111CN¥75CN¥139CN¥43
Total NC AssetsCN¥10,519CN¥10,523CN¥10,429CN¥10,428
Other AssetsCN¥0CN¥0CN¥0CN¥0
Total AssetsCN¥17,329CN¥16,558CN¥18,100CN¥18,062
Liabilities
PayablesCN¥728CN¥766CN¥920CN¥920
Short-Term DebtCN¥4,000CN¥3,399CN¥2,874CN¥2,764
Tax PayableCN¥77CN¥48CN¥91CN¥65
Deferred RevenueCN¥0CN¥0CN¥279CN¥1,766
Other Curr. Liab.CN¥336CN¥207CN¥1,368CN¥140
Total Curr. Liab.CN¥5,837CN¥5,142CN¥5,162CN¥5,591
LT DebtCN¥165CN¥166CN¥191CN¥406
Deferred Rev, NCCN¥70CN¥0CN¥59CN¥51
Deferred Tax Liab, NCCN¥66CN¥89CN¥30CN¥32
Other NC Liab.CN¥97CN¥41CN¥41CN¥106
Total NC Liab.CN¥576CN¥492CN¥427CN¥713
Other LiabilitiesCN¥0CN¥70CN¥0CN¥0
Cap. LeasesCN¥177CN¥197CN¥106CN¥117
Total LiabilitiesCN¥6,413CN¥5,704CN¥5,589CN¥6,303
Equity
Pref StockCN¥0CN¥0CN¥0CN¥0
Common StockCN¥1,860CN¥1,865CN¥1,865CN¥1,866
Retained EarningsCN¥1,425CN¥1,412CN¥3,152CN¥2,601
AOCICN¥0CN¥0CN¥1,131CN¥990
Other EquityCN¥1,317CN¥1,260CN¥1,175CN¥1,060
Total EquityCN¥10,518CN¥10,452CN¥12,100CN¥11,397
Supplemental Information
Minority InterestCN¥398CN¥402CN¥412CN¥361
Total Liab. & Tot. EquityCN¥17,329CN¥16,558CN¥18,100CN¥18,062
Net DebtCN¥2,255CN¥2,083CN¥2,049CN¥2,055